Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.13%, DAX (0.03%), CAC40 +0.23%

Sep 29 ,2026

  • Synopsis

    • European equity markets are set to open mostly higher, following a flat performance on Monday. Asian equity markets mostly lower. Japan and South Korea leading falls. US equity futures lower.

    • Focus remains on backup in bond yields and energy prices. Monday's big rate backup was attributed to recent narrative, with hawkish monetary policy expectations and upward inflation pressure. Iran headlines remain volatile. President Trump refuted Axios report he is willing to provide sanctions relief in return for concrete progress toward nuclear deal. Bloomberg also reported Iranian officials pessimistic about deal to end conflict before November midterm elections. Stalemate in negotiations underpinning oil prices. Some positive developments, with Saudis restarting Red Sea crude exports.

    • Spotlight also AI safety concerns after OpenAI canceled planned release of GPT-6.1 Astra. Reuters cited Anthropic IPO prospectus, which showed 12-fold increase in 2025 revenue. Prospectus also contained warning advanced AI could pose existential risk to humanity.

    • Also on today's agenda, PM Burnham speech at ~14:00BST at Labour Party conf. In Sweden, earliest Riksdag speaker can propose a prime minister. Newly elected Riksdag votes on the candidate. If more than half of the members vote no, the speaker will then begin the process of finding a new prime minister candidate. Chancellor Merz will deliver a speech followed by Q+A at the 25th Annual Conf of the German Council for Sustainable Development (RNE), and later in the day hosts Kazakh President Tokayev, with press conf. following the meeting. Ireland's minister of finance Harris meets with EU's Hoekstra and the EU Commissioner attends Ireland parliamentary committee as well as delivers a keynote speech at the Dublin City Univ.

    • In central banks, at the final day of ECB/ESCB Legal conf, ECB's Cipollone chairs panel at 8:45CET, whilst there are remarks by ECB's Lagarde at 13:00 and ECB's Vujčić chairs panel at 13:30. Austria central bank's Kocher gives opening remarks at 9:15CET at event title from inflation dynamics to expectations: Bridging the gap between data and policy, co-hosted with central bank of Bosnia and Herzegovina. Bundesbank conf sees introductory remarks at 10:00CET by Mauderer and fire-side chat at 12noon by Nagel, whilst other speakers include CEOs of Deutsche Bank (DBK.GR) and Commerzbank (CBK.GR) and ECB's Cipollone chairs panel at 15:15. ECB's Lane fireside chat at 20:00CET and Denmark central bank's Thomsen speech at the 50th Central Banking Seminar at the Federal Reserve Bank of New York. Norges Bank's Longva and Børsum deliver a speech for Bergen Business Council. BOE's Mann panellist at 16:00BST at event organised by McKinsey Global Institute whilst BOE's Taylor delivers the Dow Lecture at 16:30BST at NIESR. Slovakia central bank's Kažimír speech in connection with release of the bank's latest economic forecasts. World Economic Forum (WEF) publishes an annual report examining the state of gender equality worldwide. LSE event at 18:30BST title A Conversation with Alberto Musalem, President of the Federal Reserve Bank of St. Louis.

    • On macro data front, BRC shop price inflation came in slightly softer than expected in September on discounting by retailers. German inflation updates on the agenda, along with Eurozone economic sentiment indicator. BoE mortgage approvals data to provide a snapshot on housing market later. There is also central bank speak from Bundesbank chief Nagel, ECB's Lagarde, Cipollone and Vujcic. Note that Lagarde told lawmakers on Monday that ECB policy is at the upper end of the neutral range. There was a slightly paring back in October rate hike expectations on the remarks.

    • In earnings news, Hapag-Lloyd (HLAG.GR) sharply raised its FY26 earnings outlook again on strong freight demand and spot rates, now guiding EBITDA to $3.9-4.4B and EBIT to $1.25-1.75B, well above prior guidance and consensus. Pepco Group (PCO.PW) delivered its strongest quarterly like-for-like growth since its strategy reset, lifted full-year revenue, earnings, and free cash flow guidance, and approved a new up to €400M share buyback. Legrand (LR.FP) upgraded its 2030 ambitions at its Capital Markets Day, targeting 6-8% organic sales growth, 21-22% adjusted operating margin, and continued disciplined capital allocation toward M&A and buybacks. Arcadis (ARCAD.NA) unveiled 2027-29 targets alongside a restructuring that includes divesting most of its architecture and China businesses and cutting ~1,000 roles to boost margins. Also at its Investor Day, NKT (NKT.DC) reaffirmed its "Charging Forward" strategy and medium-term ambitions, outlining capital allocation priorities centered on balance sheet strength, growth investment, and shareholder returns via dividends and buybacks. On the downside, Lindt & Sprüngli (LISN.SW) cut its FY26 organic sales growth guidance to 0-2% (from 4-6%) on weak European consumer demand, though it reaffirmed its margin outlook and longer-term growth ambitions.

  • Politics/Macro/World News

    • US and Iran separately talk with mediators in latest bid to end war - Reuters

    • Britons want to get closer to the EU - and even Farage's voters agree - Politico

    • Burnham promises to roll back privatisation with government-backed grid plan - The Guardian

    • Burnham to signal end of triple lock - The Telegraph

    • Europe's LNG Shift Is Breaking the Economics of Gas Storage - Bloomberg

    • European banks push to recapture fees from BlackRock and Vanguard - FT

    • Six EU states threaten to veto EU budget billions - Handelsblatt

    • NIQ Shop Price Monitor - September 2026

      • Shop price inflation decreased to 1.4% year on year in September, against growth of 1.5% in August. This is above the 3-month average of 1.3% - BRC

  • Top company news

    • Earnings/updates

      • France

        • LR.FP (Legrand) -- provides upgraded 2030 ambitions in conjunction with 2026 CMD

        • GNFT.FP (GENFIT) -- reports H1 net income (€26.1M) vs year-ago (€10.0M)

        • GBT.FP (Guerbet) -- reports H1 net income (€32.7M) vs year-ago €1.3M

        • WAGA.FP (Waga Energy) -- reports H1 net income (€12.8M) vs year-ago (€11.6M)

      • DACHs

        • LISN.SW (Chocoladefabriken Lindt & Spruengli) -- Lindt & Sprüngli adjusts FY26 sales growth guidance downward citing subdued consumer sentiment and increased price sensitivity

        • HLAG.GR (Hapag-Lloyd) -- further raises earnings outlook for current financial year

        • 1SMA.GR (SMAG Mobile Antenna Masts GmbH) -- reports H1 revenue €12.6M vs year-ago €11.0M

        • HBH.GR (Hornbach Holding) -- reports Q2 EPS €4.69 vs year-ago €4.12; revenues and adj. EBIT in line with prelims

        • ILM1.GR (Medios) -- expects FY31 adj EBITDA to double to ~€170M -- Ambition 2031 CMD

      • Benelux

        • OCI.NA (OCI NV) -- reports H1 net income $1.0M vs year-ago $343.1M

        • ARCAD.NA (Arcadis) -- expects 2026-2029 mid- to high-teens operating EBITDA margin; to reduce ~1,000 FTEs -- CMD

      • Nordics

        • BOOZT.SS (Boozt Fashion) -- Boozt upgrades FY Revenue and Ebit outlook following strong Q3

        • NKT.DC (NKT) -- reaffirms strategic direction and presents capital allocation priorities at today's Investor Day 2026

      • Others

        • PCO.PW (Pepco Group) -- reports Q4 revenue growth constant currency +15.6% and LFL revenue growth excluding FMCG +9.5%; approves new up to €400M share buyback

      • Also due to report today includes:

        • Earnings:

          • DACHs: 2G Energy (2GB.GR)

          • France: GenSight Biologics (SIGHT.FP)

          • Southern Europe: Piraeus Port Authority (PPA.GA), Seri Industrial (SERI.IM)

          • UK: Close Brothers (CBG.LN), A.G. BARR (BAG.LN), S&U (SUS.LN), Wilmington (WIL.LN), Card Factory (CARD.LN), Ebiquity (EBQ.LN)

        • CMD/Events: BMW Group (BMW.GR) through Wed, British American Tobacco (BATS.LN) through Wed, KWS Vegetables (KWS.GR) Investor & Analyst Seminar, PayPoint (PAY.LN), INDUS Holding (INH.GR) and Multitude (MULT.GR) among participants at Zü­rich In­ves­to­ren­tag, Medacta Group (MOVE.SW) production site visit, TUI (TUI1.GR) - SdK, Scanfil (SCANFL.FH), OMV Petrom (SNP.RO)

    • M&A

      • BP.LN (BP) -- weighing sale of Brazilian biofuels business - Bloomberg

      • RXL.FP (Rexel) -- announces €500M capital increase

      • ZIM (Zim Integrated Shipping Services) -- shares turn lower amid circulation of TheMarker report

      • CBK.GR (Commerzbank) -- Unicredit may seek to replace Commerzbank CEO Bettina Orlopp next year - FT

      • 7013.JP (IHI) -- to sell Steinmüller Engineering to mutares Holding 106; terms undisclosed

      • Merchant Wealth Partner acquires stake in Ironbark Financial - Australian Financial Review

    • Healthcare

      • NOVO.B.DC (Novo Nordisk) -- Follow-up: Novo Nordisk to obtain exclusive rights to Jiangsu Hengrui Pharmaceutical's HRS-1596 globally (ex-China) for potential total value of up to $2.6B

      • UCB.BB (UCB) -- research at AANEM 2026 highlights advances in targeted treatments and patient-centered care for generalized Myasthenia Gravis

      • EKTA.B.SS (Elekta) -- announces presentation of Unity MR-Linac data

      • 13.HK (Hutchmed) -- AstraZeneca submit US NDA for Orpathys/Tagrisso in MET-driven EGFR-mutated NSCLC

      • PHARM.NA (Pharming Group) -- Pharming CEO Fabrice Chouraqui to step down with immediate effect; appoints CCO Leverne Marsh and CFO Kenneth Lynard as interim Co-CEOs

      • NYXH.BB (Nyxoah) -- appoints Liam kelly as CEO; effective 1-Oct-26

      • 600276.CH (Jiangsu Hengrui Pharmaceuticals) -- Novo to obtain exclusive rights to Jiangsu Hengrui Pharmaceutical's HRS-1596 globally (ex-China) for potential total value of up to $2.6B

      • EGTX.SS (Egetis Therapeutics) -- announces FDA approval of EMCITATE for patients with MCT8 deficiency

    • Other

      • TTE.FP (TotalEnergies) -- Transcript Intelligence: TotalEnergies Investor Day

      • BA.LN (BAE Systems) -- awarded $94.6M US Navy contract

      • ALO.FP (Alstom) -- signs contract worth ~€460M with the Royal Commission for Riyadh City (RCRC)

      • SW.FP (Sodexo) -- announces succession to its Chair of the board

      • ANTO.LN (Antofagasta) -- Two unions at Antofagasta Minerals Centinela mine reject latest contract offer

      • BAER.SW (Julius Baer Group) -- confirms conclusion of FINMA enforcement procedure

      • FRES.LN (Fresnillo) -- Transcript Intelligence: Fresnillo at Americas Mining Forum

      • HOC.LN (Hochschild Mining) -- Transcript Intelligence: Hochschild Mining at Americas Mining Forum

      • SpaceX successful Starship launch mission ended early; execs call for self-improving AI oversight in intraday themes (28-Sep)

  • Key rating changes

    • Upgrades

      • GRE.SM (Grenergy Renovables) -- to outperform at Bernstein

      • SLR.SM (Solaria Energia) -- to outperform at Bernstein

      • BVI.FP (Bureau Veritas) -- to overweight from neutral at JPMorgan

      • IBE.SM (Iberdrola) -- to buy from hold at Deutsche Bank

      • FABG.SS (Fabege) -- to hold from sell at ABG Sundal Collier

      • SILEX.SS (Silex Microsystems) -- to hold from sell at ABG Sundal Collier

    • Downgrades

      • FME.GR (Fresenius Medical Care) -- Fresenius Medical Care transferred, downgraded to hold from buy at Berenberg

      • RTO.LN (Rentokil Initial) -- to equal-weight from overweight at Morgan Stanley

      • ERF.FP (Eurofins Scientific) -- to market perform from outperform at Bernstein

      • BILL.SS (Billerud) -- to hold from buy at Jefferies

      • METSO.FH (Metso Corp.) -- to hold from buy at Danske Bank

      • KALMAR.FH (Kalmar) -- to sell from hold at Danske Bank

      • ALFA.SS (Alfa Laval) -- to hold from buy at Danske Bank

      • TREL.B.SS (Trelleborg) -- to hold from buy at Danske Bank

  • Data

    • Nikkei (1.52%) to 64875.70

    • Hang Seng (0.75%) to 24457.44

    • Shanghai Composite (0.08%) to 3820.63

    • S&P futures (24.3) vs prior close of 7746.8

    • €-$ (0.0015) or (0.13%) to 1.1356

    • $-¥ (0.04) or (0.02%) to 157.34

    • €-¥ (0.28) or (0.16%) to 178.67

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.